Literature DB >> 7985710

The continuing utility of bronchoalveolar lavage to diagnose opportunistic infection in AIDS patients.

R P Baughman1, M N Dohn, P T Frame.   

Abstract

PURPOSE: To determine whether bronchoalveolar lavage (BAL) remains a useful technique in assessing human immunodeficiency virus (HIV)-infected patients with pulmonary symptoms. PATIENTS AND METHODS: All HIV-infected patients with pulmonary symptoms referred to a university hospital-based pulmonary service underwent bronchoscopy and BAL within 24 hours of referral. All samples were handled in a standardized fashion. The results of the lavage were compared with chest roentgenograms and clinical results.
RESULTS: A total of 894 lavages were performed on HIV-infected patients over a 7-year period. The overall diagnostic yield was 60%, with 420 patients having Pneumocystis carinii. Infections other than P carinii were found in 185 cases, including 75 lavages with P carinii and another infection. The other infections included Mycobacterium tuberculosis (17 patients), Mycobacterium kansasii (15 patients), Histoplasma capsulatum (24 patients), Cryptococcus neoformans (17 patients), and bacterial infection (103 patients). For 364 lavages, no diagnosis was made. Chest roentgenograms were not useful in predicting what infection would be diagnosed. There was no difference in the yield of BAL over the 7-year period, despite the introduction of aerosol pentamidine prophylaxis and antiretroviral therapy.
CONCLUSION: Bronchoscopy with BAL continues to have a role in the evaluation of HIV-infected patients with pulmonary symptoms.

Entities:  

Mesh:

Year:  1994        PMID: 7985710     DOI: 10.1016/0002-9343(94)90346-8

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  13 in total

Review 1.  Diagnosis of pneumonia and monitoring of infection eradication.

Authors:  M Ruiz; C Arosio; P Salman; T T Bauer; A Torres
Journal:  Drugs       Date:  2000-12       Impact factor: 9.546

2.  [Bronchoalveolar lavage].

Authors:  M Tötsch; J Guzman; D Theegarten; K W Schmid; U Costabel
Journal:  Pathologe       Date:  2007-09       Impact factor: 1.011

3.  Utility of routine testing of bronchoalveolar lavage fluid for cryptococcal antigen.

Authors:  S M Kralovic; J C Rhodes
Journal:  J Clin Microbiol       Date:  1998-10       Impact factor: 5.948

4.  Sterols of Pneumocystis carinii hominis organisms isolated from human lungs.

Authors:  E S Kaneshiro; Z Amit; J Chandra; R P Baughman; C Contini; B Lundgren
Journal:  Clin Diagn Lab Immunol       Date:  1999-11

5.  Development and evaluation of a molecular viability assay for Pneumocystis carinii.

Authors:  N Maher; S Vermund; M Lasbury; C Lee; M Bartlett; T R Unnasch
Journal:  J Clin Microbiol       Date:  2000-05       Impact factor: 5.948

6.  Sequences of Pneumocystis carinii f. sp. hominis strains associated with recurrent pneumonia vary at multiple loci.

Authors:  S P Keely; J R Stringer
Journal:  J Clin Microbiol       Date:  1997-11       Impact factor: 5.948

7.  Evaluation of sensitivity of multiplex PCR for Detection of Mycobacterium tuberculosis and Pneumocystis jirovecii in clinical samples.

Authors:  Sirirat Boondireke; Mathirut Mungthin; Peerapan Tan-ariya; Petchara Boonyongsunchai; Tawee Naaglor; Anan Wattanathum; Sompong Treewatchareekorn; Saovanee Leelayoova
Journal:  J Clin Microbiol       Date:  2010-07-14       Impact factor: 5.948

8.  Concurrent Pneumocystis jirovecii and pulmonary histoplasmosis in an undiagnosed HIV patient.

Authors:  Ahsan Wahab; Siddique Chaudhary; Mahin Khan; Susan Jane Smith
Journal:  BMJ Case Rep       Date:  2018-01-26

9.  A case report of pulmonary coinfection of Strongyloides stercoralis and Pneumocystis jiroveci.

Authors:  A J Bava; Mm Romero; R Prieto; A Troncoso
Journal:  Asian Pac J Trop Biomed       Date:  2011-08

10.  Co-infection of Mycobacterium tuberculosis and Pneumocystis jirovecii in the Iranian Patients With Human Immunodeficiency Virus.

Authors:  Maryam Fatemeh Sheikholeslami; Javid Sadraei; Parissa Farnia; Mehdi Forozandeh Moghadam; Hamid Emadi Kochak
Journal:  Jundishapur J Microbiol       Date:  2015-02-20       Impact factor: 0.747

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.